News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
TDxd for treating HER2-positive breast cancer with brain and/or leptomeningeal metastases
Aug 17, 2024, 14:04

TDxd for treating HER2-positive breast cancer with brain and/or leptomeningeal metastases

Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared on X about recent paper by Takahiro Nakayama et al., titled “Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)” published on Breast Cancer.

Authors: Takahiro Nakayama, Naoki Niikura, Takashi Yamanaka, Mitsugu Yamamoto, Kazuo Matsuura, Kenichi Inoue, Sachiko Takahara, Hironori Nomura, Shosuke Kita, Miki Yamaguchi, Tomoyuki Aruga, Nobuhiro Shibata, Akihiko Shimomura, Yuri Ozaki, Shuji Sakai, Daisuke Takiguchi, Takehiko Takata, Armin Bastanfard, Kazuhito Shiosakai, Junji Tsurutani

Image

“ Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM) | Breast Cancer.”

Source: Elisabetta Bonzano/X

Akihiko Shimomura Armin Bastanfard Breast Cancer cancer Daisuke Takiguchi Elisabetta Bonzano HER2 positive breast cancer Hironori Nomura IRCCS San Matteo Polyclinic Foundation Junji Tsurutani Kazuhito Shiosakai Kazuo Matsuura Kenichi Inoue leptomeningeal metastases Miki Yamaguchi Mitsugu Yamamoto Naoki Niikura Nobuhiro Shibata OncoDaily Oncology Sachiko Takahara Shosuke Kita Shuji Sakai Takahiro Nakayama Takashi Yamanaka Takehiko Takata Tomoyuki Aruga Trastuzumab deruxtecan Yuri Ozaki
Special Coverage
Celebrities
Feb 22, 2025, 11:40
Remembering Saxophonist James Casey: His Battle with Colon Cancer and Advocacy
Career
Feb 22, 2025, 11:36
Joseph H. Antin Received ASTCT Lifetime Achievement Award at 2025 Tandem Meetings
Science
Feb 22, 2025, 11:28
Myeloma Paper of the Day, February 22nd, suggested by Robert Orlowski
Blog
Feb 22, 2025, 11:22
Yan Leyfman: Great experience speaking at the NSHSS Pre-Medicine Workshop
Insight
Feb 22, 2025, 11:15
Henrik Ullum: The urgent need to protect WHO is also an opportunity
Oncolibrary
Feb 22, 2025, 11:02
New Paper Alert: Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
Blog
Feb 22, 2025, 10:57
Tsetsegsaikhan Batmunkh: Factsheets for parents on childhood cancers and essential medicines in the Mongolian
Blog
Feb 22, 2025, 10:47
Akhilesh Bind: Advancing political leadership for equitable cancer care
Blog
Feb 22, 2025, 10:41
Nominations close for the 2025 Szent-Györgyi Prize for Progress in Cancer Research - NFCR
Blog
Feb 22, 2025, 06:28
Michael Sapienza: Breaking the stigma associated with CRC screening with Lead From Behind
Blog
Feb 22, 2025, 05:23
Sanam Loghavi: Excited to see the draft agenda for the inaugural Women in Hematology meeting
Blog
Feb 22, 2025, 05:18
Francisco J. Esteva: The clinical applications of PARPi across various cancers